Editorial comment--Cooling matrix metalloproteinases to improve thrombolysis in acute ischemic stroke.
Montaner
Joan
J
D000208:Acute Disease; D000818:Animals; D002545:Brain Ischemia / Q000150:complications / Q000201:enzymology / Q000628:therapy*; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D003131:Combined Modality Therapy; D004195:Disease Models, Animal; D004660:Encephalitis / Q000209:etiology / Q000517:prevention & control; D004789:Enzyme Activation / Q000187:drug effects / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007036:Hypothermia, Induced; D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D020521:Stroke / Q000150:complications / Q000201:enzymology / Q000628:therapy*; D016896:Treatment Outcome
D004791:Enzyme Inhibitors; D005343:Fibrinolytic Agents; D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases